30

ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD.

301234 · SHE · Healthcare / Medical Devices

111.58CNY-7.95 (-6.65%)

Price History

Full chart

Market Stats

Previous Close119.53
Open109.78
Day Range109.21 – 118.98
52-Week Range30.89 – 139.74
Volume2.54M
Market Cap9.22B
P/E (TTM)387.57
Forward P/E0.00
EPS0.35
Dividend Yield0.15%
Beta0.04
50-Day Avg95.63
200-Day Avg53.51

About

Anhui Hongyu Wuzhou Medical Manufacturer Co.,LTD. engages in the research, development, production, and sale of disposable sterile infusion medical devices in China. The company offers safety hypodermic needle, safety blood collection needle, safety blood collection set, conventional syringes, hypodermic and blood collection needle, and insulin syringes and pen needles, as well as infusion, blood administration, burette, and scalp vein sets. It also exports its products to approximately 80 countries. The company was founded in 2011 and is headquartered in Anqing, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Hongyu Zhang
  • Employees856
  • HeadquartersNo. 2 Guanyin Road, Anqing, China, 246400, China
  • Websitehttps://www.hongyu-wuzhou.com

Leadership

  • Mr. Hongyu ZhangGM & Director · b. 1968
  • Ms. Lanlan PanDeputy GM, Board Secretary & Employee Director · b. 1968
  • Mr. Hui JinDeputy General Manager · b. 1965
  • Mr. Jian Ming LiuDeputy General Manager · b. 1970

Financials

Income Statement

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue486.96M471.24M512.96M547.11M533.68M477.43M458.28M
Growth (%)--3.23%+8.85%+6.66%-2.46%-10.54%-4.01%
Cost of Revenue379.22M375.39M397.22M424.43M419.95M392.46M391.48M
Gross Profit107.74M95.85M115.74M122.68M113.73M84.97M66.80M
Gross Margin22.12%20.34%22.56%22.42%21.31%17.80%14.58%
Operating Expense38.45M25.62M29.94M53.13M48.94M44.52M48.16M
Operating Income69.28M70.23M85.81M69.55M64.79M40.46M18.64M
Operating Margin14.23%14.90%16.73%12.71%12.14%8.47%4.07%
EBITDA88.01M83.28M85.57M96.89M101.77M85.23M61.77M
EBITDA Margin18.07%17.67%16.68%17.71%19.07%17.85%13.48%
Net Income52.90M56.74M68.39M70.93M60.27M39.97M18.89M
Net Income Margin10.86%12.04%13.33%12.96%11.29%8.37%4.12%
R&D9.92M10.02M11.78M13.09M13.48M12.97M9.74M
R&D as % of Total Revenue2.04%2.13%2.30%2.39%2.53%2.72%2.13%
Interest Expense10.96M1.06M1.03M632.53K12.24K18.97K18.83K
Interest Expense % of Total Revenue2.25%0.23%0.20%0.12%0.00%0.00%0.00%

Balance Sheet

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets319.56M327.47M383.07M844.60M848.18M872.67M869.04M
Total Liabilities181.92M133.09M120.30M121.15M98.47M110.17M108.02M
Total Equity137.63M194.38M262.77M723.44M749.71M762.50M761.02M
Cash67.00M49.25M43.33M104.17M271.32M155.68M81.08M

Cash Flow

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow88.13M55.00M62.58M111.45M81.79M88.90M73.38M
Capital Expenditure23.58M33.69M56.51M163.96M70.87M37.00M19.78M
Free Cash Flow64.54M21.31M6.07M-52.51M10.92M51.90M53.61M
Dividends Paid13.12M36.06M1.03M620.45K34.00M27.18M20.37M
FCF to OCF73.24%38.74%9.70%-47.12%13.35%58.38%73.05%
Dividend Paid to FCF20.32%169.22%17.02%-1.18%311.48%52.37%38.00%

Earnings

Report DateSep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------
EPS Actual0.260.320.190.340.260.090.150.170.180.080.080.070.120.010.120.11
Surprise----------------
Timing----------------

Key Statistics & Ratios

Market Cap9.22B
Enterprise Value7.88B
Trailing P/E387.57
Forward P/E0.00
Price / Sales20.76
Price / Book10.88
EPS0.35
Book Value11.22
Revenue (TTM)444.41M
Gross Profit (TTM)70.36M
EBITDA61.81M
Profit Margin5.34%
Operating Margin6.33%
Return on Equity3.13%
Return on Assets1.75%
Shares Outstanding68.00M
Shares Float20.60M
Beta0.04
Dividend Yield0.15%
Dividend Rate0.20
Payout Ratio57.29%

Dividends

20261×
0.20Jun 1, 2026
20251×
0.30May 29, 2025
20241×
0.40Jun 25, 2024
20231×
0.50Jun 9, 2023